You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 5, 2024

ZOLADEX Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


Which patents cover Zoladex, and when can generic versions of Zoladex launch?

Zoladex is a drug marketed by Tersera and is included in two NDAs.

The generic ingredient in ZOLADEX is goserelin acetate. There are five drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the goserelin acetate profile page.

AI Research Assistant
Questions you can ask:
  • What is the 5 year forecast for ZOLADEX?
  • What are the global sales for ZOLADEX?
  • What is Average Wholesale Price for ZOLADEX?
Summary for ZOLADEX
Drug patent expirations by year for ZOLADEX
Drug Prices for ZOLADEX

See drug prices for ZOLADEX

Recent Clinical Trials for ZOLADEX

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Prostate Cancer FoundationPhase 2
Panbela TherapeuticsPhase 2
Novartis PharmaceuticalsPhase 1

See all ZOLADEX clinical trials

US Patents and Regulatory Information for ZOLADEX

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Tersera ZOLADEX goserelin acetate IMPLANT;IMPLANTATION 019726-001 Dec 29, 1989 RX Yes Yes ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Tersera ZOLADEX goserelin acetate IMPLANT;IMPLANTATION 020578-001 Jan 11, 1996 RX Yes Yes ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for ZOLADEX

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Tersera ZOLADEX goserelin acetate IMPLANT;IMPLANTATION 020578-001 Jan 11, 1996 ⤷  Sign Up ⤷  Sign Up
Tersera ZOLADEX goserelin acetate IMPLANT;IMPLANTATION 019726-001 Dec 29, 1989 ⤷  Sign Up ⤷  Sign Up
Tersera ZOLADEX goserelin acetate IMPLANT;IMPLANTATION 020578-001 Jan 11, 1996 ⤷  Sign Up ⤷  Sign Up
Tersera ZOLADEX goserelin acetate IMPLANT;IMPLANTATION 020578-001 Jan 11, 1996 ⤷  Sign Up ⤷  Sign Up
Tersera ZOLADEX goserelin acetate IMPLANT;IMPLANTATION 019726-001 Dec 29, 1989 ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

International Patents for ZOLADEX

See the table below for patents covering ZOLADEX around the world.

Country Patent Number Title Estimated Expiration
Japan S6113480 ⤷  Sign Up
Hungary 186904 PROCESS FOR PRODUCING RETARDE PHARMACEUTICAL COMPOSITIONS ⤷  Sign Up
Finland 820467 ⤷  Sign Up
Ukraine 75351 AUTOMATICALLY OPERABLE SAFETY SHIELD SYSTEM FOR USE WITH SYRINGE (VARIANTS) ⤷  Sign Up
Czechoslovakia 199674 METHOD OF PRODUCING POLYPEPTIDES ⤷  Sign Up
>Country >Patent Number >Title >Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.